ArticleJournal of materials science. Materials in medicine2026
ADA-GEL composite hydrogel films incorporating mesoporous bioactive glass nanoparticles and silver-doped bioactive glass nanoparticles for biomedical applications.
Article in Journal of materials science. Materials in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hydrogels made from natural polymers are widely used in biomedical engineering as they resemble the extracellular matrix. Alginate dialdehyde-gelatin (ADA-GEL) hydrogels are notable for their biocompatibility, biodegradability, and adjustable crosslinking. However, their limited mechanical strength and bioactivity present significant challenges for use in tissue regeneration and wound healing. To overcome these issues, this study explores the addition of 0.1 and 1 wt.% mesoporous bioactive glass nanoparticles (MBGNs) or silver-doped bioactive glass nanoparticles (Ag-BGNs) into ADA-GEL hydrogels to create composite hydrogel films. These nanocomposites were tested in terms of printability, swelling, degradation, antibacterial effects, and in vitro compatibility using MG-63 cells (osteosarcoma cells). MBGNs improved the hydrogels' osteogenic ability and structural stability. At the same time, Ag-BGNs provided vigorous antibacterial activity, especially against Staphylococcus aureus and Escherichia coli, without significantly affecting cell viability and morphology. The use of bioactive and antimicrobial nanoparticles in the ADA-GEL matrix offers a promising approach for developing new soft biomaterials for applications such as bone regeneration, wound healing, and implant coatings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.